期刊
JOURNAL OF GENETICS AND GENOMICS
卷 46, 期 5, 页码 235-245出版社
SCIENCE PRESS
DOI: 10.1016/j.jgg.2019.03.013
关键词
GOLM1; miR-145; mTOR; Exosome; Hepatocellular carcinoma
资金
- National Basic Research Program of China 973 Program [2015CB553802]
- National Natural Science Foundation of China [81730078]
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [CIFMS2016-I2M-1-001]
Golgi membrane protein 1 (GOLM1/GP73) is a serum marker of hepatocellular carcinoma (HCC). We have previously shown that mTOR promoted tumorigenesis of HCC through stimulating GOLM1 expression. In this study, we demonstrated that the mammalian target of rapamycin (mTOR) was a negative regulator of microRNA-145 (miR-145) expression. miR-145 inhibited GOLM1 expression by targeting a coding sequence of GOLM1 gene. GOLM1 and miR-145 were inversely correlated in human HCC tissues. GOLM1enriched exosomes activated the glycogen synthase kinase-3b/matrix metalloproteinases (GSK-3b/MMPs) signaling axis of recipient cells and accelerated cell proliferation and migration. In contrast, miR145 suppressed tumorigenesis and metastasis. We suggest that mTOR/miR-145/GOLM1 signaling pathway should be targeted for HCC treatment. Copyright (C) 2019, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据